Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting

Research To Practice | Oncology Videos · Jun 3, 2025 · 1h 22m

Featuring perspectives from Dr Daniel George, Dr Leonard G Gomella and Dr Evan Y Yu, moderated by Dr George, including the following topics:

Introduction (0:00)

Current Treatment Landscape for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) — Dr Gomella (3:42)

Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr Yu (35:37)

Emerging Role of AKT Inhibition for mHSPC — Dr George (1:06:18)

CME information and select publications